Endothelin-mediated Vasoconstriction

Endothelin-Mediated Vasoconstriction is a physiological mechanism in the regulation of liver blood flow wherein vasoconstriction of hepatic sinusoids and portal tracts is induced by the binding of endothelin peptides, primarily endothelin-1, to vascular smooth muscle receptors, distinguishing it from other vasoconstrictive pathways by its origin in endothelial-derived signaling and potent, sustained vascular tone modulation.

2.4K

Publications

139.9K

Citations

8.2K

Authors

1.5K

Institutions

Publications per year

2017–2026

79

Authors

8.2K

  1. MY
    Masashi Yanagisawa

    The University of Texas Southwestern Medical Center, United States

    42 publications · 7.3K citations

    33

    h-index

  2. KG
    Katsutoshi Goto

    University of Tsukuba, Japan

    33 publications · 3.6K citations

    26

    h-index

  3. JP
    John Pernow

    Karolinska Institutet, Sweden

    31 publications · 1.3K citations

    25

    h-index

  4. LE
    Lars Edvinsson

    Lund University, Sweden

    42 publications · 1.4K citations

    24

    h-index

  5. MC
    Martine Clozel

    Roche (Switzerland), Switzerland

    25 publications · 2.7K citations

    23

    h-index

1–5 of 8.2K

Venues

  1. Circulation

    60 publications · 9.8K citations

    49

    h-index

  2. Hypertension

    82 publications · 6.4K citations

    46

    h-index

  3. British Journal of Pharmacology

    BJP · 108 publications · 5.4K citations

    45

    h-index

  4. Journal of Cardiovascular Pharmacology

    160 publications · 5.4K citations

    41

    h-index

  5. 37

    h-index

1–5